Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suzan Parada"'
Autor:
Claiborne Miller-Davis, Gwenyth R. Wallen, Georgie Cusack, Tannia P. Cartledge, Suzan Parada, Jan Yates
Publikováno v:
Nurse Education Today. 31:638-642
Health professionals, particularly nurses, continue to struggle with the expanding role of genetics information in the care of their patients. This paper describes an evaluation study of the effectiveness of a hybrid basic genetics course for healthc
Publikováno v:
Anesthesiology. 96:1053-1061
Background There are few repeated dose-controlled trials of N-methyl-d-aspartate glutamate receptor antagonists in patients with neuropathic pain. The authors sought to evaluate two low-affinity N-methyl-d-aspartate antagonists using a novel two-stag
Autor:
Raymond A. Dionne, Richard Harvey Gracely, Sharon M. Gordon, Suzan Parada, David B. MacLean, Christine N. Sang, Navil F. Sethna, Mitchell B. Max
Publikováno v:
Clinical Pharmacology & Therapeutics. 64:562-568
Background Animal studies suggest that substance P, a peptide that preferentially activates the neurokinin-1 (NK1) receptor, is involved in pain transmission, with particular importance in pain after inflammation. Methods The analgesic efficacy of CP
Publikováno v:
The Journal of Neuroscience. 16:7331-7335
The contribution of the sympathetic nervous system (SNS) to pain, mechanical allodynia (MA), and hyperalgesia in humans is controversial. A clearer understanding is crucial to guide therapeutic use of sympatholytic surgery, blocks, and drug treatment
Autor:
Vesta Salehi, Suzan Khoromi, Suzan Parada, Athos Patsalides, Jennifer M. Meegan, Mitchell B. Max
Publikováno v:
The journal of pain. 6(12)
Chronic lumbar radicular pain is the most common neuropathic pain syndrome. This was a double-blind, randomized, 2-period crossover trial of topiramate (50 to 400 mg) and diphenhydramine (6.25 to 50 mg) as active placebo to assess the efficacy of top
Publikováno v:
Anesthesiology. 96(5)
There are few repeated dose-controlled trials of N-methyl-d-aspartate glutamate receptor antagonists in patients with neuropathic pain. The authors sought to evaluate two low-affinity N-methyl-d-aspartate antagonists using a novel two-stage design.Th
Publikováno v:
Clinical Pharmacology & Therapeutics. 59:216-216